chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENT STARTED DEVELOPING REDNESS AND WARMTH AROUND VACCINE SITE  A FEW DAYS AFTER VACCINATION. PT REPORTED TO PHARMACY AND REPORTED THE REACTION. THE PATIENT WAS ADVISED TO REPORT TO MD AS SOON AS POSSIBLE TO GET TREATMENT FOR REACTION.
Fever 101, screaming episode lasting >4 hrs; episodes of convulsions (petit mal);
Shingles/ flu shot  Sharp radiating pressure chest pain.pain   every 4 to 5 hours
feeling a lot of pain; DIscomfort two days later; area is inflamed; Area is swolled; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN (feeling a lot of pain), DISCOMFORT (DIscomfort two days later), INJECTION SITE INFLAMMATION (area is inflamed) and INJECTION SITE SWELLING (Area is swolled) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (feeling a lot of pain), DISCOMFORT (DIscomfort two days later), INJECTION SITE INFLAMMATION (area is inflamed) and INJECTION SITE SWELLING (Area is swolled). At the time of the report, PAIN (feeling a lot of pain), DISCOMFORT (DIscomfort two days later), INJECTION SITE INFLAMMATION (area is inflamed) and INJECTION SITE SWELLING (Area is swolled) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.  It was reported that patient was vaccinated with the Moderna booster a few days ago and experienced symptoms.   Reporter did not allow further contact
7 days after he received the vaccine, he has been experiencing severe pain in the upper right arm.  He has been taking ADVIL and TYLENOL and had to go see his doctor because there was no relief with OTC meds.
Premature rupture of membranes prompting admission to hospital - needs steriods for lung maturation for baby - water brook early; pre-term delivery via induction.  Yes - first preg.; May 28th - due date  - late April was the date of delivery and 4lb. and 5 oz for birth weight -  baby was there for 4 weeks.  feeding/growing low birth weight; prematurity - was cause of the four weeks.
flu like symptoms; vomiting; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), VOMITING (vomiting), CHILLS (chills) and PYREXIA (fever) outcome was unknown.            Concomitant medication was not provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-026841, US-MODERNATX, INC.-MOD-2021-026874 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-026841: US-MODERNATX, INC.-MOD-2021-026874:
Vaccine administered from vial which has been punctured for more than 6 hours; A spontaneous report was received from a nurse for a 64-year-old male patient who received Moderna's COVID-19 Vaccine and experienced vaccine administered from vial which has been punctured for more than 6 hours.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number 026L20A) for prophylaxis of COVID-19 infection in the left deltoid.   On 30 Dec 2020, between 8:00-11:00 am, the patient was administered a vaccine dose from a vial that had been punctured on 29 Dec 2020 at 6:00 pm. No adverse events were reported. No treatment information was provided..   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, vaccine administered from vial which has been punctured for more than 6 hours, was recovered/resolved on 30 Dec 2020.; Reporter's Comments: This case concerns the 64-year old male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) from a vial, which had been punctured for more than 6 hours. On 30 Dec 2020, between 8:00-11:00 am, the patient was administered a vaccine dose from a vial that had been punctured on 29 Dec 2020 at 6:00 pm. No adverse events were reported. Reported event is unlisted for COVID-19 Vaccine (mRNA-1273) and causality assessment was assessed as not applicable.
This isnt something brand new, but I was having elevated heart rate that was about 160 which last about 45min before calling 911. When EMS arrived, they did an EKG, and I was in atrofibe.
Patient's daughter reported to us today that the patient's arm is swollen (baseball size) and there is a good amount of pain.
Information has been received from a physician concerning a 14 month old white female who on 21-MAR-2007 was vaccinated with ROTATEQ first dose (LOT# 656191/1365F) at the age of 2 months. Subsequent doses of ROTATEQ were given on 30-MAY-2007 (LOT 656383/0235U) at age 4 months and third dose on 18JUL-2007 (LOT # 656705/0241U) age age 6 months. There was no concomitant medication. On 18-APR-2008 the patient developed diarrhea and dehydration and was hospitalized. The patient was hospitalized for three days. The patient had a stool culture which was positive on 19-APR-2008 for rotavirus antigen. On 20-APR-2008 the patient had recovered. Further information received noted that the patient was admitted to the hospital on 17-APR-2008 (previous onset date of event 18-APR-2008) and was treated with IV fluids only. On 20-APR-2008 the patient was discharged from the hospital. On 23-APR-2008 the patient was seen for a well visit in the office and was noted to be fine. The patients appetite was noted as improved. No further information available.
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with the first dose of HPV Vaccine (Lot not provided) Subsequently, the day after she was vaccainted the patient developed a sort of rash all over her body. The physician recommended that the patient treat the rash with Benadryl, which the patient did. subsequently, the rash resolved and no additional treatment was needed. Additional information has been requested.
Vaccine had a low temp excursion.  Revaccinated 10/26/2022
Administration error:  Patient given COVID19 vaccine 5-11 dose, although she is 12 years old.  No adverse reaction noted.
My mom died one month after the second maderna shot it made her very sick and she never recovered . Headache stomach ache chills fever shaking and death
Patient received the COVID-19 vaccine (first dose Pfizer). He reported no previous adverse reactions to vaccines. During the 15 minute monitoring period, the patient fainted. He appeared pale and sweaty, and he reported dizziness, lightheadness, and blacking out. He laid down for several minutes and sat up in the chair with assistance when he was no longer lightheaded. His blood pressure was 108/71 with heart rate 76.  EMS checked the patient and cleared him approximately 20-25 minutes after receiving the vaccine.
10/10 - Child complained of leg hurting and walking stiff. 10/11 R leg swollen from hip to low knee, double size knee joint swollen, can't see kneecap. Child won't walk on it. 5" around and some 3" over from site toward inner thigh, hot to touch. Given Motrin, doctor put on Preva , Benadryl.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history and no known allergies. The patient took concomitant medications statins, thyroid, vitamin D and baby aspirin. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) positive, notes: initial positive test; (03Mar2023) positive, notes: Tested positive 03Mar. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 21Feb2023 to 26Feb2023. The patient developed typical cold symptoms 2 days after completing Paxlovid treatment, which kept getting worse through today. Cough, runny nose, malaise. Tested positive 03Mar2023, 12 days after initial positive test and COVID symptom onset and six days after last day of Paxlovid treatment.  The information on the batch/lot number for BNT162B2, BNT162B2 OMI BA.4-5 has been requested and will be submitted if and when received.
Patient developed satellite vesicles and cellulitis at and around the site of the vaccine.  Approx. 8 additional vesicles.
Pt. got FluMist (H1N1). Immediately after, he broke out with welts/urticarial rash on cheeks.
On 02/05/2001 the patient experienced sweats, diarrhea and pain. On 02/15/2001 the experienced a stiff neck. Unspecified medical attention was sought. FOLLOW-UP information has been received from a physician who reports he checked with the patient and she denies any adverse reaction to the vaccine.
Patient was due for a TB test and received 0.1 mL of the IPV instead of TB. The patient was given the correct dosage of TB afterward.
suspected vaccination failure; still got it/ having them now; pain/it hurt; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not recovered/not resolved.   The reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient received Shingles vaccine, last year from the date of reporting. The patient was vaccinated with Shingles vaccine and it still gave him/her shingles at the time of reporting. The patient agreed with some of them and stated that, it hurt more than having a baby. The patent was in so much pain and stated that nothing helped and asked advice.  This case was considered as suspected vaccination failure, since the details regarding the laboratory confirmation of shingles was not provided.
Minutes p/receiving vax mom noticed multiple hive-like welts @ inject site, diarrhea x 2 days, strange behavior off & on, sudden outbursts of temper uncharacteristic for pt, even in sleep, t103, 102 & 101, OM confirmed;
This case was reported by a nurse and described the occurrence of an unspecified illness in a female patient who received Hep-B vaccine.    The patient's medical history included developmental delay and "seizure behaviour".  On 04 AUG 2000, the patient received the first dose of Engerix_B.  On 07 SEP 2000, the patient received the second dose of Energix-B.  Approximately eight months after the second dose, on 14 MAY 2001 the patient received the third dose of Energix-B.  This is longer than the recommedended interval of five months between the second and third doses of Energix-B.  At an unspecified time following the third administration of Energix-B, on an unspecified date, the patient experienced an unspecified illness.  The illness was ongoing at the time of follow-up.
I got the flu even with the shot; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 06-DEC-2020.  This case involves a patient of unknown age and gender who got the flu even with the shot (Influenza), while he/she received vaccine Influenza Vaccine.   The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site.   On an unknown date, the patient reported that never before, but this was the first year the patient got the flu even with the shot.   It was not reported if the patient received a corrective treatment.  Outcome of the event was unknown, at the time of reporting.  There will be no information available on the batch number for this case.  The reporter assessed the causal relationship with suspect vaccine as related.
fever of 103 that was not controlled by APAP;rash devel 2 days p/vax consulted MD by phone 3JAN96 & 4JAN96;
patient had both Pfizer vaccines at an outside pharmacy and reports she is now diagnosed with Uveitis Glaucoma Hyphema (UGH) Syndrome and now has to have surgery. This patient states symptoms started after getting the COVID vaccine and she did not have any issues with her vision prior to receiving the vaccine
Anxiety; Lightheadedness; This spontaneous case was reported by a physician and describes the occurrence of ANXIETY (Anxiety) and DIZZINESS (Lightheadedness) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    No medical history was provided by the reporter.    On 19-Jul-2020, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 mg. On 17-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced ANXIETY (Anxiety) and DIZZINESS (Lightheadedness). At the time of the report, ANXIETY (Anxiety) and DIZZINESS (Lightheadedness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Apr-2021, Blood glucose: increased (abnormal) increased.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment were not reported
Swelling under nose and under the lower lip along with redness.  Client released home after evaluation by onsite paramedic and physician at 3:43 pm.
I had two shots the flu and the bivalent COVID. My reactions were fainting, vomiting, hard breathing, skin irritation at site and all over body. I had this for days after
Extreme Joint pain and swelling around joints started 1 to 2 weeks into shot. Knee to wrist to hand to foot. 3rd week same, and a very mild case of shingles. Joint pain was worse the second shot, started right away and was much more intense, not sleeping from the pain. Nothing helped for meds. went to dr several times to talk about the pain,
16 h after vaccine administered: shaking rigors, myalgia, arthralgia, headache.  Fever 103.5F, dripping diaphoresis.  Recovered after 3 days.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 04-JAN-2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), administered by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. ZOSTAVAX did not prevent shingles as intended. During 2016 (specific date unknown), the patient was treated at an urgent care and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care the treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events is unknown. Additional information has been requested.
Received shot Sat. morning--then woke up around 1;00 am that night vomiting.  I vomited on the floor beside the bed and then again on the bathroom floor before I could make it to the toilet.  I went back to bed--woke up around 4:00 am realizing I was too weak to clean the mess and called for my son on the floor below.  I spent the day taking my pain meds and trying to take in enough fluid to not be dangerously dehydrated.  I did not go to the Emergency Room or a walk in clinic because I was afraid they would admit me to the hospital which would only make me worse.  My son stays with me and gives me better care.   I developed muscle pain like I have never felt.  It was not a body ache--it was muscle pain.  It hurt to sit or to lie down. Any movement at all cause extreme hurting in the muscles.   I could pinch my arm, legs, or back and feel PAIN not just a pinch.  I could tell Monday morning that I was no longer getting worse and felt too tired to get out to the doctors office so did not call him.  I continued to gradually feel better, and by Wednesday I was weak but better.  Writing this I see how foolish I was to not call the doctor and will give my son instructions to call him if I seem sick and do not call the doctor myself.  My not going was based in knowing I was given a killed virus--I would have gone to the emergency room if I had not felt I knew the cause of my sickness.  I ask myself how I would resist the live flu unless this was a faulty batch of vaccine which is why I am reporting the incident.
Arm was sore for hours after, and the next day I started having tightness in my chest, and it stayed for two days and three days after vaccine My chest was tight all day. I did have Covid back in September of 2020
Pale, faint, clammy, B/P 100/54, HR 68.
No additional AE reported.; administered to an adult; This spontaneous report was received from a medical assistant and refers to a 26-year-old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 30-JUN-2021, the adult patient was inadvertently vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 milliliter, lot # T029104 has been verified to be a valid lot number, expiration date 23-FEB-2022, albumin status rHA (formulation, strength, frequency and route of administration were not reported) for prophylaxis. No other adverse event was reported.
Red, swollen rash, 1 1/2inches in diameter around injection site.  Slightly sore to the touch.
Patient was calling in because she stated she's been taking her Mayzent medication but she believes she may be pregnant. Patient stated she hasn't gotten her period in a couple months and has been spitting up a bit but has not taken a pregnancy test. Patient also stated she recently took the J&J vaccine and didn't know if her current symptoms were related to that.
Initial report received from a health care professional on 17 November 2011. A patient (age and sex not reported) received an intradermal injection of FLUZONE Intradermal, sanofi pasteur Inc. lot number not reported, on an unknown date. The patient's medical history was not reported. The patient had half inch welt with one inch circumference, flushing of the face and numbness on the left side of the face. The patient had a slight blood pressure drop 400. The patient "just did feel well". The outcome was not reported. Documents held by sender: None.
I was having outpatient ankle replacement surgery , it was an overnight stay. Apparently I was having problems with my oxygen levels and had to stay hospitalized for five days, diagnosis was acute respiratory failure.
Pt. presented to hospital with worsening shortness of breath, dry cough, fatigue, loss of smell, and poor appetite for about 1 week on 04/06/21.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Information about concurrent conditions, concomitant medication and medical history was not provided. On an unspecified date the patients were vaccinated with doses of improperly stored GARDASIL (lot#, dose, route and frequency were not provided). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
I was taken to emergency room with AFib. I was later admitted into hospital on September 12 - September 16.
Painful, itchy, raised welt at vaccination site. Approx 3 inches in diameter, warm to touch and very firm.
Patient was to receive the Bivalent COVID 12 years and up vaccine and instead received the Monovalent COVID 12 years and up in error
Information has been received from a registered nurse referring to unspecified patients of unknown age and gender. Since the excursion on 21-OCT-2015, doses of MMR II (lot # K001230, expiration date 27-JAN-2016; Lot # L000459, expiration date 06-JAN-2017; dose and route unknown) which were exposed to temperatures outside of the recommended range, had been administered to the patients on unspecified dates in 2015. No adverse experience was reported. This is one of several reports received from the same source. Additional information has been requested.
Itchy skin on outside of thighs (both sides) and upper arms (both).  The itch skins appears to be large raised bumps much like hives.  They were red and hot to the touch.